Diurnal, Seasonal, and Monthly Variations in Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

被引:3
|
作者
Maan, Abhishek [1 ]
Sherfesee, Lou [2 ]
Lexcen, Daniel [2 ]
Heist, E. Kevin [1 ]
Cheng, Alan [2 ]
机构
[1] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA USA
[2] Medtron, 8200 Coral Sea St,MVS 2, Mounds View, MN 55112 USA
关键词
defibrillators; diurnal variation; ventricular arrhythmias; SUDDEN CARDIAC DEATH; CIRCADIAN VARIATION; MYOCARDIAL-INFARCTION; TACHYARRHYTHMIAS; TACHYCARDIA; MORTALITY; PLATELET; CORONARY; INTERVAL; THERAPY;
D O I
10.1016/j.jacep.2019.05.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to assess the variations in ventricular arrhythmia (VA) occurrence according to seasons, months of the year, days of the week, and the time of day in a large implantable cardioverter-defibrillator patient population. BACKGROUND Limited data exist on how VA occurrence varies as a function of time. METHODS Data from 6 prospective studies were pooled to assess VA frequency over time. All adjudicated episodes of VAs <= 500 ms were included. VA distribution as a function of hour, day, month, and season were assessed through the construction of 4 negative binomial models. The models included a random patient effect and offset for days spent in each time period. RESULTS Among 3,969 patients, 7,126.8 cumulative device-years with an average follow-up duration of 1.8 +/- 1.4 years/patient were analyzed. VA occurrence was higher in the spring than the summer (0.86% vs. 0.70%; p = 0.009) but not significantly different from the fall (0.74%; p = 0.069) or winter (0.84%; p = 0.732). The estimated probability of occurrence of at least 1 VA episode in each 1-h block during the hours of 8 AM to 10 PM over 365 days (0.10% to 0.12%) was higher (estimated 35% to 63% higher) than the referent period of midnight to 1 AM (0.07%). No significant variations in VA occurrence were observed according to weekday and individual months of the year. CONCLUSIONS Significantly higher VA occurrence in the spring and during the hours of 8 AM to 10 PM were observed. Additional studies are needed to further understand the reasons for these observations, which may involve variations in temperature or differences in catecholamine triggers. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:979 / 986
页数:8
相关论文
共 50 条
  • [41] TREATMENT OF VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS AND ANTITACHYCARDIA PACEMAKERS
    WINTERS, SL
    CAMUNAS, J
    ERGIN, A
    ESTIOKO, M
    GOMES, JA
    CURRENT OPINION IN CARDIOLOGY, 1989, 4 (04) : 555 - 558
  • [42] Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
    Maass, Alexander H.
    Cox, Moniek G. P. J.
    JAMA CARDIOLOGY, 2022, 7 (11) : 1175 - 1175
  • [43] The role of implantable cardioverter-defibrillators in asymptomatic patients with left ventricular dysfunction
    Goldenberg, Ilan
    Huang, David T.
    Nielsen, Jens Cosedis
    EUROPEAN HEART JOURNAL, 2020, 41 (21) : 2035 - 2035
  • [44] Role of Implantable Cardioverter-Defibrillators in Patients with Left Ventricular Assist Devices
    Bonilla, D.
    Firstenberg, M. S.
    Blais, D.
    Louis, L. B.
    Weiss, R.
    Hummel, J. D.
    Yanssens, T.
    Wissman, S.
    Sun, B.
    Sudhakar, C. B. Sai
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S85 - S85
  • [45] Use of implantable cardioverter-defibrillators in patients with left ventricular assist devices
    Kuhne, Michael
    Sakumara, Michaela
    Reich, Stephen
    Oral, Hakan
    Bogun, Frank
    Chugh, Aman
    Jongnarangsin, Krit
    Good, Eric
    Pagani, Francis
    Pelosi, Frank, Jr.
    Morady, Fred
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 24A - 25A
  • [46] Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy
    Roguin, A
    Bomma, CS
    Nasir, K
    Tandri, H
    Tichnell, C
    James, C
    Rutberg, J
    Crosson, J
    Spevak, PJ
    Berger, RD
    Halperin, HR
    Calkins, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (10) : 1843 - 1852
  • [47] Patients with hemodynamically tolerated ventricular tachycardia require implantable cardioverter-defibrillators
    Callans, David J.
    CIRCULATION, 2007, 116 (10) : 1196 - 1203
  • [48] Current practice of ventricular tachycardia ablation in patients with implantable cardioverter-defibrillators
    Dagres, Nikolaos
    Cantu, Francesco
    Geelen, Peter
    Lewalter, Thorsten
    Proclemer, Alessandro
    Blomstrom-Lundqvist, Carina
    EUROPACE, 2012, 14 (01): : 135 - 137
  • [49] High grade left ventricular systolic asynchrony as a cause of ventricular arrhythmias in patients with left ventricular dysfunction and implantable cardioverter-defibrillators
    Gessner, M
    Kainz, W
    Blazek, G
    Gruska, M
    Domaus, C
    Gaul, G
    EUROPEAN HEART JOURNAL, 2000, 21 : 552 - 552
  • [50] Ventricular Arrhythmias in Left Ventricular Assist Device Patients With Implantable Cardioverter Defibrillators
    Stahl, Erika
    Pauwaa, Sunil
    Modi, Sejal
    Pappas, Pat
    Tatooles, Antone
    Bhat, Geetha
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S54 - S54